Anti-Inflammatory Strategy for M2 Microglial Polarization Using Retinoic Acid-Loaded Nanoparticles.

Area of Science:

• Neuroscience
• Biomaterials Science
• Immunology

Background:

• Microglial cell activation drives brain inflammation and hinders neural repair in various disorders.
• Modulating microglial phenotype is crucial for developing effective neuroprotective strategies.

Purpose of the Study:

• To investigate retinoic acid-loaded polymeric nanoparticles (RA-NP) for modulating microglial response.
• To evaluate RA-NP's potential in promoting an anti-inflammatory and neuroprotective M2 phenotype in microglia.

Main Methods:

• Characterization of RA-NP internalization and cytotoxicity in N9 microglial cells.
• Immunocytochemical analysis of pro- and anti-inflammatory mediator expression (nitric oxide, inducible nitric oxide synthase, arginase-1, interleukin-4).
• Assessment of microglia morphology, neuronal survival, and postsynaptic protein-95 expression in organotypic hippocampal slice cultures.

Main Results:

• RA-NP were effectively internalized by microglial cells without significant cytotoxicity.
• RA-NP treatment inhibited lipopolysaccharide (LPS)-induced nitric oxide and inducible nitric oxide synthase, while promoting arginase-1 and interleukin-4.
• RA-NP induced an M2 microglia morphology, enhanced neuronal survival, and restored postsynaptic protein-95 expression in inflamed brain slices, outperforming free retinoic acid.

Conclusions:

• RA-NP effectively shift microglia towards an anti-inflammatory M2 phenotype.
• RA-NP demonstrate significant neuroprotective effects, promoting tissue viability and neuronal survival.
• RA-NP represent a promising therapeutic candidate for managing brain inflammatory diseases.